BTIG analyst Marie Thibault raised the firm’s price target on Masimo (MASI) to $178 from $170 and keeps a Buy rating on the shares after its Q3 earnings beat and guidance raise. The firm is positive on how quickly the new management and board are moving to enhance the company’s P&L, and with a backdrop of healthy consumables revenue growth and hospital contracting, BTIG believes Masimo is set up to outperform in Q4 and into 2025, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MASI:
- Masimo upgraded to Outperform at Raymond James on ‘much cleaner’ story
- Masimo upgraded to Outperform from Market Perform at Raymond James
- Masimo price target raised to $171 from $160 at Wells Fargo
- Masimo Corp. Reports Strong Q3 2024 Performance
- Masimo Reports Strong Q3 2024 Financial Results
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
